Antibody Therapies for Progressive Multiple Sclerosis and for Promoting Repair

Progressive multiple sclerosis (PMS) is clinically distinct from relapsing–remitting MS (RRMS). In PMS, clinical disability progression occurs independently of relapse activity. Furthermore, there is increasing evidence that the pathological mechanisms of PMS and RRMS are different. Current therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Havla, Joachim, Hohlfeld, Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294105/
https://www.ncbi.nlm.nih.gov/pubmed/35289375
http://dx.doi.org/10.1007/s13311-022-01214-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294105/
https://www.ncbi.nlm.nih.gov/pubmed/35289375
http://dx.doi.org/10.1007/s13311-022-01214-x

Ejemplares similares